Ifp Advisors, Inc Bluebird Bio, Inc. Transaction History

Ifp Advisors, Inc

$2.42 Billion
Q2 2024

A detailed history of Ifp Advisors, Inc transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 5,000 shares of BLUE stock, worth $1,750. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,000

Holding current value

$1,750

% of portfolio

0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	BUY	$0.85 - $1.26 $4,250 - $6,300	5,000 New	5,000 $4,000
Q2 2022 Sep 06, 2022	BUY	$2.94 - $5.23 $1,602 - $2,850	545 New	545 $100,000
Q2 2022 Aug 12, 2022	SELL	$2.94 - $5.23 $1,602 - $2,850	-545 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$4.07 - $10.6 $2,218 - $5,777	545 New	545 $2,000
Q3 2021 Oct 06, 2021	SELL	$11.24 - $21.0 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$18.04 - $22.09 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	SELL	$16.59 - $33.89 $16,789 - $34,296	-1,012 Closed	0 $0
Q4 2020 Jan 25, 2021	SELL	$27.5 - $37.92 $357 - $492	-13 Reduced 1.27%	1,012 $46,000
Q3 2020 Oct 29, 2020	BUY	$34.44 - $43.75 $309 - $393	9 Added 0.89%	1,025 $57,000
Q2 2020 Aug 05, 2020	BUY	$27.12 - $45.97 $650 - $1,103	24 Added 2.42%	1,016 $61,000
Q1 2020 May 12, 2020	BUY	$26.16 - $63.5 $7,037 - $17,081	269 Added 37.21%	992 $45,000
Q4 2019 Jan 17, 2020	SELL	$46.96 - $61.67 $1,502 - $1,973	-32 Reduced 4.24%	723 $64,000
Q3 2019 Nov 07, 2019	BUY	$59.47 - $93.1 $44,424 - $69,545	747 Added 9337.5%	755 $72,000
Q1 2019 May 15, 2019	SELL	$64.44 - $104.11 $82,289 - $132,948	-1,277 Reduced 99.38%	8 $2,000
Q4 2018 Jan 23, 2019	SELL	$59.1 - $93.26 $33,273 - $52,505	-563 Reduced 30.47%	1,285 $82,000
Q3 2018 Oct 25, 2018	SELL	$88.86 - $117.49 $26,124 - $34,542	-294 Reduced 13.73%	1,848 $0
Q2 2018 Aug 07, 2018	BUY	$99.64 - $127.59 $31,087 - $39,808	312 Added 17.05%	2,142 $0
Q1 2018 Jun 03, 2019	SELL	$105.8 - $150.94 $21,689 - $30,942	-205 Reduced 10.07%	1,830 $326,000
Q1 2018 May 09, 2018	BUY	$105.8 - $150.94 $21,689 - $30,942	205 Added 11.2%	2,035 $0
Q4 2017 Jan 24, 2018	BUY	$81.25 - $130.7 $89,375 - $143,770	1,100 Added 150.68%	1,830 $0
Q3 2017 Oct 30, 2017	SELL	$57.74 - $91.42 $121,773 - $192,804	-2,109 Reduced 74.29%	730 $100,000
Q2 2017 Jun 03, 2019	BUY	N/A	2,689 Added 1792.67%	2,839 $298,000
Q1 2017 Jun 03, 2019	SELL	N/A	-50 Reduced 25.0%	150 $14,000
Q4 2016 Jun 03, 2019	BUY	N/A	150 Added 300.0%	200 $12,000
Q2 2016 Jun 03, 2019	BUY	N/A	42 Added 525.0%	50 $2,000
Q1 2016 Jun 03, 2019	BUY	N/A	8	8 $2,000

Others Institutions Holding BLUE

# of Institutions

151

Shares Held

63.4M

Call Options Held

264K

Put Options Held

428K

Black Rock Inc. New York, NY

15.4M
Shares

$5.4 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

10.5M
Shares

$3.67 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

4.68M
Shares

$1.64 Million
0.0% of portfolio
Pictet Asset Management Sa Geneva 73, V8

4.67M
Shares

$1.63 Million
0.02% of portfolio
State Street Corp Boston, MA

3.84M
Shares

$1.34 Million
0.0% of portfolio

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account